We are live on ! Find out more
PA

Pinnacle Associates Portfolio holdings

AUM $7.78B
1-Year Est. Return 45.07%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+45.07%
3 Year Est. Return
+102.47%
5 Year Est. Return
+115.95%
10 Year Est. Return
+586.2%
AUM
$6.34B
AUM Growth
+$402M
Cap. Flow
-$27.6M
Cap. Flow %
-0.43%
Top 10 Hldgs %
20.1%
Holding
857
New
39
Increased
287
Reduced
431
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 23.92%
2 Healthcare 11.41%
3 Financials 10.16%
4 Industrials 9.61%
5 Consumer Discretionary 7.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDC
851
DELISTED
M.D.C. Holdings, Inc.
MDC
-187,921
Closed -$10.4M
MIXT
852
DELISTED
MIX TELEMATICS LIMITED
MIXT
-99,236
Closed -$854K
AYX
853
DELISTED
Alteryx Inc
AYX
-23,969
Closed -$1.13M
IMGN
854
DELISTED
Immunogen Inc
IMGN
-1,011,792
Closed -$30M
GOL
855
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
-15,150
Closed -$54.8K
DOC
856
DELISTED
PHYSICIANS REALTY TRUST
DOC
-27,192
Closed -$362K

Similar funds

Pinnacle Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Pinnacle Associates held 857 positions worth $6.34B, up 6.8% from $5.94B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Pinnacle Associates's Q1 2024 filing shows 39 new, 287 increased, 431 reduced and 22 closed positions. Its largest new stake was GMO US Quality ETF: 548,868 shares worth $16.3M. The largest sale was Immunogen Inc, an estimated $30M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Pinnacle Associates's largest Q1 2024 buy was GMO US Quality ETF: 548,868 shares worth $16.3M.
  • Pinnacle Associates added most to Vanguard Morningstar Small-Cap ETF in Q1 2024, an estimated $6.49M increase.
  • Pinnacle Associates's biggest Q1 2024 reduction was Microsoft, cutting an estimated $6.76M.
  • Pinnacle Associates fully exited Immunogen Inc in Q1 2024, selling an estimated $30M.
  • Pinnacle Associates's ten largest holdings make up 20% of its $6.34B portfolio in Q1 2024.
  • Pinnacle Associates opened 39 new positions and closed 22 in Q1 2024.
  • Pinnacle Associates's portfolio value rose 6.8% quarter-over-quarter to $6.34B.

Based on Pinnacle Associates's 13F filing for Q1 2024, filed 26 Apr 2024.